UP AND UP 5-SYMPTOM DIGESTIVE RELIEF- bismuth subsalicylate tablet 
Target Corporation

----------

5 Symptom Digestive Relief

Drug Facts

Active ingredient (in each caplet)

Bismuth subsalicylate 262 mg

Purpose

Upset stomach reliever and anti-diarrheal

Uses

relieves

heartburn
indigestion
nausea
upset stomach
diarrhea

Warnings

Reye's syndrome

Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rare but serious illness.

Allergy alert:

Contains salicylate. Do not take if you are

allergic to salicylates (including aspirin)
taking other salicylate products

Do not use if you have

an ulcer
a bleeding problem
bloody or black stool

Ask a doctor before use if you have

fever
mucus in the stool

Ask a doctor before use if you are taking any drug for

anticoagulation (thinning of the blood)
diabetes
gout
arthritis

When using this product a temporary, but harmless, darkening of the stool and/or tongue may occur.

Stop use and ask a doctor if

symptoms get worse or last more than 2 days
ringing in the ears occurs or loss of hearing occurs
diarrhea lasts more than 2 days

If pregnant or breast feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center immediately.1-800-222-1222.

Directions

swallow with water, do not chew
adults and children 12 years and older: 2 caplets every 1/2 to 1 hour as needed
do not exceed 8 doses (16 caplets) in 24 hours
use until diarrhea stops but not more than 2 days
children under 12 years: ask a doctor
drink plenty of clear fluids to help prevent dehydration caused by diarrhea

Other information

each caplet contains: calcium 27 mg
sodium 3 mg
salicylate 99 mg
low sodium
sugar free
avoid excessive heat (over 104°F or 40°C)

Inactive ingredients

calcium carbonate, crospovidone, D&C red#27 aluminum lake, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate.

PRINCIPAL DISPLAY PANEL -

NDC 11673-125-20

Compare to active ingredient in Pepto-Bismol® Caplets*

5- symptom digestive relief

relief of upset stomach, nausea, heartburn, indigestion, diarrhea

40 CAPLETS

*This product is not manufactured or distributed by Procter & Gamble Inc. the distributor of PEPTO-BISMOL®

TAMPER EVIDENT DO NOT USE IF PRINTED SEAL UNDER CAP IS TORN OR MISSING.

245 05 0375 R01 ID285492

Dist.by Target Corp., Mpls ., MN 55403

©2017 Target Brands, Inc.

Shop Target.com

Guest Services 1-800-910-6874

up and up 5-symptom digestive relief bismuth subsalicylate,262 mg/antidiarrheal  Caplet
UP AND UP 5-SYMPTOM DIGESTIVE RELIEF 
bismuth subsalicylate tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11673-125
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BISMUTH SUBSALICYLATE (UNII: 62TEY51RR1) (BISMUTH CATION - UNII:ZS9CD1I8YE, SALICYLIC ACID - UNII:O414PZ4LPZ) BISMUTH SUBSALICYLATE262 mg
Inactive Ingredients
Ingredient NameStrength
calcium carbonate (UNII: H0G9379FGK)  
CROSPOVIDONE (120 .MU.M) (UNII: 68401960MK)  
D&C RED NO. 27 (UNII: 2LRS185U6K)  
magnesium stearate (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
Product Characteristics
ColorPINK (mottled light pink) Scoreno score
ShapeOVAL (Oblong Caplet) Size16mm
FlavorImprint Code RP125
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11673-125-2040 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product09/07/2015
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00809/07/2015
Labeler - Target Corporation (006961700)

Revised: 11/2023
Document Id: 91551ad6-6a59-42aa-b25b-200f55e21856
Set id: 6462e224-5ee7-4556-90f2-994eaf89b71b
Version: 7
Effective Time: 20231116
 
Target Corporation